Other potential indications for cinacalcet include medullary thyroid cancer–associated diarrhea (29), bile acid diarrhea (30), and tyrosine kinase inhibitor diarrhea (19), in which increased CFTR-mediated Cl– secretion is a major cause of diarrhea. This evidence concerns the gene CFTR and medullary thyroid gland carcinoma.